<DOC>
	<DOCNO>NCT03093363</DOCNO>
	<brief_summary>The impact pharmacist 's intervention asthma control well demonstrate , effect inflammatory marker FENO ( Fractional exhale nitric oxide ) asthmatic patient little studied literature . The aim study investigate impact pharmacist 's intervention FENO patient see clinical practice pneumologist secondary university center .</brief_summary>
	<brief_title>Impact Hospital Pharmacist 's Intervention FENO ( Fractional Exhaled Nitric Oxide ) Asthmatic Patients</brief_title>
	<detailed_description />
	<criteria>Adult asthmatic ( definition asthma : FEV1 [ force expiratory volume 1 second ] reversibility least 12 % 200 mL 400 mcg salbutamol and/or PC20M [ provocative concentration methacholine cause 20 % fall FEV1 ] &lt; 16 mg/mL ) unchanged increase dose inhaled corticosteroid prescribe pneumologist visit FENO ( fractional exhale nitric oxide ) &gt; = 25 ppb Treatment oral corticosteroid treat asthma exacerbation within 4 week visit pneumologist Exclusion Criteria study : Change dose ICS ( inhaled corticosteroid ) followup 3 month pharmacist 's intervention Severe asthma exacerbation require oral corticosteroid within 4 week followup visit ( 3 month pharmacist 's intervention )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>